论文部分内容阅读
自美国胆固醇教育计划(NCEP)成人治疗组第3次报告ATPⅢ于2001年8月发表后,又有5个使用他汀类药物以临床事件为终点的大型试验——HPS、PROVE-IT、PROSPER、ASCOT-LLA及ALLHAT-LLA,陆续公布了研究结果。根据这些新的循证医学资料,NCEP协调委员会对ATPⅢ进行了补充和修改,于2004
Since the release of the ATPIII ATPIII in the Adult Treatment Unit of the United States Cholesterol Education Program (NCEP) in August 2001, there have been five more large trials using statins for clinical events - HPS, PROVE-IT, PROSPER, ASCOT-LLA and ALLHAT-LLA, one after another announced the results. Based on these new evidence-based medical information, the NCEP Coordinating Committee supplemented and modified ATP III in 2004